FITC anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_FITC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) FITC (filled histogram) or rat IgG2b, κ FITC isotype control (open histogram).
  • GK1.5_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) FITC (filled histogram) or rat IgG2b, κ FITC isotype control (open histogram).
See FITC spectral data
Cat # Size Price Quantity Avail. Save
100405 50 µg $25
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100406 500 µg $90
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, and immunoprecipitation1,2. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
Product Citations
  1. Zongyi Y, et al. 2017. PLoS One. 10.1371/journal.pone.0189617. PubMed
  2. Reynolds CJ, et al. 2018. Sci Rep. 8:672. PubMed
  3. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  4. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  5. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  6. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  7. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  8. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  9. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  10. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  11. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  12. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  13. Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
  14. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  15. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  16. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  17. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  18. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  19. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  20. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  21. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  22. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  23. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  24. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  25. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  26. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  27. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  28. Blaszczak AM, et al. 2019. J Immunol. 202:2451. PubMed
  29. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  30. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  31. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  32. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  33. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  34. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  35. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  36. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  37. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  38. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  39. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  40. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  41. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  42. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  43. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  44. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  45. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  46. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  47. Khosravi N, et al. 2018. Cancer Immunol Res. 0.797222222. PubMed
  48. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  49. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  50. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  51. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  52. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  53. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  54. Sega E, et al. 2008. Int J Radiat Oncol Biol Phys. 71:559. PubMed
  55. Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed
  56. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  57. Mencl S, et al. 2014. J Neuroimmunol. 274:125. PubMed
  58. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  59. White C, et al. 2014. J Immunol. 193:5933. PubMed
  60. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  61. Hart B, et al. 2015. PLoS Negl Trop Dis. 9: 0004046. PubMed
  62. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  63. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  64. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  65. Toomer K, et al. 2016. J Immunol. 196: 3665 - 3676. PubMed
  66. Ahmari N, et al. 2016. Physiol Genomics. 48: 526 - 536. PubMed
  67. Vigeland C, et al. 2016. PLoS One. 11: 0163288. PubMed
  68. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  69. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  70. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  71. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  72. Bryan Hart, Sunhee Lee 2016. PLoS Negl Trop Dis. 10:e0005229. PubMed
  73. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  74. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  75. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  76. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  77. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  78. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  79. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  80. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  81. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  82. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  83. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  84. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  85. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  86. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  87. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  88. Wang Z, et al. 2020. J Clin Invest. 130:3717. PubMed
  89. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  90. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  91. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  92. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  93. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  94. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  95. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  96. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  97. Ma X, et al. 2021. Cell Metabolism. 33(5):1001-1012.e5. PubMed
  98. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  99. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  100. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
RRID
AB_312690 (BioLegend Cat. No. 100405)
AB_312691 (BioLegend Cat. No. 100406)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account